Related Experiment Video
Updated: Oct 15, 2025

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
Published on: October 30, 2018
Prospects for liver fluke vaccines
Jing Zhang1, Ying Sun2, Jingtong Zheng3
1Department of Intensive Care Unit, First Hospital of Jilin University, Changchun, Jilin, Changchun, Xinmin Street NO.71, 130021, China; Department of Pathogenobiology, College of Basic Medical Sciences, Jilin University, Jilin, Changchun Xinmin Street NO.126, 130000, China.
Abstract:
Fasciola spp., Opisthorchis spp. and Clonorchis sinensis are common liver flukes that can cause a variety of diseases, mainly cholangiocarcinoma induced by clonorchiasis and liver damage and associated pathology induced by fascioliasis. Because these trematodes are parasites of humans and domestic animals, they have greatly affected the economy of agricultural industries and public health worldwide. Due to the emergence of drug resistance and the living habits of flukes, among other reasons, a possibility of reinfection remains even when antiparasitic drugs are used. Therefore, developing a safe, efficient and cost-effective vaccine against trematodes is an important goal. Here, we briefly describe the progress in the development of vaccines against liver flukes. Related innovations may provide effective protection against these helminths and the diseases that they cause.

